Disseminated tuberculosis and lung cancer associated with infliximab treatment of rheumatoid arthritis.

Sankaranarayanan Viji, Krishna G, Gould M, Chitkara R., Clin Pulmon Med.12(2):115-120., 2005 Mar 01

Investigators

Abstract

Tumor necrosis factor (TNF)-α blockers have emerged as valuable tools in the treatment of active rheumatoid arthritis. The increased incidence of reactivated latent mycobacterial infection following institution of infliximab therapy has been reported.

However, less is known about the risk of malignancy with use of anti-TNF antibodies. We present a case of disseminated tuberculosis, possible infection with Mycobacterium fortuitum, and lung cancer in association with infliximab therapy in a 55-year-old man with active rheumatoid arthritis who had received previously isoniazid chemoprophylaxis.

We review the existing literature on anti-TNF agents and risk of tuberculosis and malignancy.

Pubmed Abstract

Pubmed AbstractOpens New Window

Associated Topics

Related Publications

Nodular invasive tracheobronchitis due to Aspergillus in a patient with systemic lupus erythematosus.

Angelotti T, Krishna G, Scott J, Berry G, Weinacker A.
Lupus. 2002;11(5):325-8.
2002 May 01

Increasing prevalence of primary biliary cholangitis and reduced mortality with treatment.

Lu M, Zhou Y, Haller IV, Romanelli RJ, VanWormer JJ, Rodriguez CV, Anderson H, Boscarino JA, Schmidt MA, Daida YG, Sahota A, Vincent J, Bowlus CL, Lindor K, Zhang T, Trudeau S, Li J, Rupp LB, Gordon SC; FOLD Investigators.
Clin Gastroenterol Hepatol. pii: S1542-3565(17)31529-X. doi: 10.1016/j.cgh.2017.12.033. [Epub ahead of print]
2017 Dec 22

Epitope-specific immunotherapy of rheumatoid arthritis: clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II tria

http://www.ncbi.nlm.nih.gov/pubmed/19877047
Arthritis Rheum. 2009 Nov;60(11):3207-16. doi: 10.1002/art.24916
2009 Nov 09